30% in LL arm can't be right. Maybe Dr. Yo meant that a 30% reduction in mortality won't be good enough based on the Hahn comment that 35% reduction is what we dream of in clinical trials (when talking about convalescent plasma approval).

All just speculation on my part trying to explain Dr. Yo's head scratcher comment.